Results 81 to 90 of about 351,529 (205)
The Distortionary Effects of Government Procurement: Evidence from Medicaid Prescription Drug Purchasing [PDF]
The federal-state Medicaid program insures 43 million people for virtually all of the prescription drugs approved by the FDA. To determine the price that it will pay for a drug treatment, the government uses the average price in the private sector for ...
Fiona Scott Morton, Mark Duggan
core
_M. tuberculosis_ interactome analysis unravels potential pathways to drug resistance [PDF]
Drug resistance is a major problem for combating tuberculosis. Lack of understanding of how resistance emerges in bacteria upon drug treatment limits our ability to counter resistance.
Karthik Raman, Nagasuma Chandra
core +1 more source
By applying nonlinear mixed‐effect (NLME) models, model‐integrated evidence (MIE) approaches are able to analyze bioequivalence (BE) data with pharmacokinetic end points that have sparse sampling, which is problematic for non‐compartmental analysis (NCA).
Xiaomei Chen +6 more
doaj +1 more source
Value-Based Generic Drug Evaluation Focus on Chinese Real-World Evidence. [PDF]
Lu J, Ying X, Li Z.
europepmc +1 more source
Estimations of generic drug entry in Brazil using count versus ordered models [PDF]
Two major changes in Brazilian legislation during the 1990s reshaped the local pharmaceutical industry: the ratification of the TRIPS agreement including a provision for pipeline inventions in 1996, and a Generic Drug Act in 1999, which introduced ...
Caballero, Barbara, Fiuza, Eduardo P. S.
core
Background/Objectives: Intrathecal drug delivery is essential for treating CNS disorders, but the safety of commonly used excipients such as citric acid/sodium citrate (SC) remains unclear.
Jue Wang +13 more
doaj +1 more source
An empirical study of the impact of generic drug competition on drug market prices in China. [PDF]
Yina C, Pengcheng L, Haomiao N, Yang C.
europepmc +1 more source
FDA Approval of Drugs and Devices: Preemption of State Laws for “Parallel” Tort Claims [PDF]
The U.S. Supreme Court’s important ruling in Mutual Pharmaceutical Co., Inc. v. Bartlett concerns whether the Food and Drug Administration’s (“FDA”) approval of a generic drug insulates the drug manufacturer from liability under state tort laws from ...
Boumil, Marcia
core

